Merck & Co begins US filing of Ebola vaccineMerck & Co has begun a rolling filing in the US of its Ebola Zaire vaccine, known as Share XMerck & Co begins US filing of Ebola vaccinehttps://pharmaphorum.com/news/merck-co-begins-us-filing-of-ebola-vaccine/
AZ sells rights to RSV virus drug to Sobi for $1.5bnAstraZeneca has agreed to sell the rights to its drug Synagis (palivizumab) to Swedish Orphan Biovitrum (Sobi) for Share XAZ sells rights to RSV virus drug to Sobi for $1.5bnhttps://pharmaphorum.com/news/az-sells-rights-to-rsv-virus-drug-to-sobi-for-1-5bn/
Eyeing Novartis deal, Akcea trumpets lipoprotein drug dataIonis affiliate Akcea Pharma has new data for its antisense drug for elevated lipoprotein levels in patients with Share XEyeing Novartis deal, Akcea trumpets lipoprotein drug datahttps://pharmaphorum.com/news/eyeing-novartis-deal-akcea-trumpets-lipoprotein-drug-data/
Are dual ARVs the new frontier in a maturing HIV market?Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and Share XAre dual ARVs the new frontier in a maturing HIV market?https://pharmaphorum.com/sales-marketing/are-dual-arvs-the-new-frontier-in-a-maturing-hiv-market/
Digital health round up: UK government invests millions in AIThis week saw the announcement of millions of pounds of investment from the UK government into artificial intelligence Share XDigital health round up: UK government invests millions in AIhttps://pharmaphorum.com/digital/digital-health-round-up-uk-government-invests-millions-in-ai/
European digital health innovationHealthcare and the pharmaceutical industry are redefining their roles for the modern age as digital health tech radically Share XEuropean digital health innovationhttps://pharmaphorum.com/digital/european-digital-health-innovation/
CAR-Ts – a new weapon in the fight against cancerCAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies Share XCAR-Ts – a new weapon in the fight against cancerhttps://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
How to achieve digital success in pharma’s communicationsDemystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for Share XHow to achieve digital success in pharma’s communicationshttps://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/
Future-proofing pharma with a multichannel approach to sales and marketingDeploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and Share XFuture-proofing pharma with a multichannel approach to sales and marketinghttps://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/
Metrics to meaning: demonstrating the value of medical communications Share XMetrics to meaning: demonstrating the value of medical communicationshttps://pharmaphorum.com/debates-insight-sales-marketing/metrics-to-meaning-demonstrating-the-value-of-medical-communications/
The devil’s in the e-detail: what HCPs really want from you Share XThe devil’s in the e-detail: what HCPs really want from youhttps://pharmaphorum.com/digital/the-devils-in-the-e-detail-what-hcps-really-want-from-you/
Can simulated datasets unlock the potential of patient data? Share XCan simulated datasets unlock the potential of patient data?https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/
Intelligent HCP engagement in Europe – what do doctors want?The opportunity to engage with HCPs digitally has never been more prevalent. We are witnessing a desire from Share XIntelligent HCP engagement in Europe – what do doctors want?https://pharmaphorum.com/digital/intelligent-hcp-engagement-europe/
Understanding blockchain – a practical guide for life sciences companiesWithin the life science industry, uptake of blockchain is in the early stages, but with investment levels in Share XUnderstanding blockchain – a practical guide for life sciences companieshttps://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/
The innovation challenge: realising the true potential of digitalDigital transformation; it would be easy to assume that it is widespread across the life science industry, and Share XThe innovation challenge: realising the true potential of digitalhttps://pharmaphorum.com/digital/insights-digital/innovation-challenge-true-potential-digital/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success Share XEisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s successhttps://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
Part three: Oncology shaping the future of personalised healthcare Share XPart three: Oncology shaping the future of personalised healthcarehttps://pharmaphorum.com/video/part-three-oncology-shaping-future-personalised-healthcare/
Pharmaceutical Microbiology UK Speaker Interview Released from Fresenius Kabi AB Share XPharmaceutical Microbiology UK Speaker Interview Released from Fresenius Kabi ABhttps://pharmaphorum.com/partner-content/pharmaceutical-microbiology-uk-speaker-interview-released-from-fresenius-kabi-ab/
J+D, Pharma Forecasting Experts Partner with Epiphany, Oncology Data Experts Share XJ+D, Pharma Forecasting Experts Partner with Epiphany, Oncology Data Expertshttps://pharmaphorum.com/partner-content/jd-pharma-forecasting-experts-partner-with-epiphany-oncology-data-experts/
Parallel Trade for Pharma: Addressing Competition law and FMD challenges Share XParallel Trade for Pharma: Addressing Competition law and FMD challengeshttps://pharmaphorum.com/partner-content/parallel-trade-for-pharma-addressing-competition-law-and-fmd-challenges/
Updates on Delivery Mechanisms of RNA-Based Drugs at RNA Therapeutics Conference Share XUpdates on Delivery Mechanisms of RNA-Based Drugs at RNA Therapeutics Conferencehttps://pharmaphorum.com/partner-content/updates-on-delivery-mechanisms-of-rna-based-drugs-at-rna-therapeutics-conference/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
Ashfield Healthcare Communications appoints new Global Commercial Director Share XAshfield Healthcare Communications appoints new Global Commercial Directorhttps://pharmaphorum.com/partner-content/ashfield-healthcare-communications-appoints-new-global-commercial-director/
